Nektar TherapeuticsNKTRNASDAQ
Loading
Price to Sales HistoryNormalizing
Percentile Rank71
3Y CAGR+41.1%
5Y CAGR-8.2%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+41.1%/yr
vs -1.9%/yr prior
5Y CAGR
-8.2%/yr
Recent acceleration
Acceleration
+43.0pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 12.91 | +564.6% |
| 2024 | 1.94 | +63.0% |
| 2023 | 1.19 | -74.1% |
| 2022 | 4.59 | -81.1% |
| 2021 | 24.30 | +22.4% |
| 2020 | 19.85 | -39.8% |
| 2019 | 32.96 | +564.4% |
| 2018 | 4.96 | -83.6% |
| 2017 | 30.27 | +192.4% |
| 2016 | 10.35 | - |